EGFR and non-small cell lung carcinoma: Therefore, our study retrospectively reviewed patients with advanced NSCLC after EGFR-TKIs failure in Shanghai Chest Hospital and analyzed clinical outcomes, safety and relevant influential factors of different treatment options.